APA (7th ed.) Citation

Brunoni, A. R., Carracedo, A., Amigo, O. M., Pellicer, A. L., Talib, L., Carvalho, A. F., . . . Cappi, C. (2020). Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: Ancillary analysis of a double-blind, placebo-controlled trial. Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 42(2), 128. https://doi.org/10.1590/1516-4446-2019-0620

Chicago Style (17th ed.) Citation

Brunoni, Andre R., et al. "Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT Polymorphisms with TDCS and Escitalopram Efficacy: Ancillary Analysis of a Double-blind, Placebo-controlled Trial." Brazilian Journal of Psychiatry / Revista Brasileira De Psiquiatria 42, no. 2 (2020): 128. https://doi.org/10.1590/1516-4446-2019-0620.

MLA (9th ed.) Citation

Brunoni, Andre R., et al. "Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT Polymorphisms with TDCS and Escitalopram Efficacy: Ancillary Analysis of a Double-blind, Placebo-controlled Trial." Brazilian Journal of Psychiatry / Revista Brasileira De Psiquiatria, vol. 42, no. 2, 2020, p. 128, https://doi.org/10.1590/1516-4446-2019-0620.